Navigation Links
Clinical tests for medicines made from genetically modified plants
Date:7/21/2011

This release is available in German.

UK regulators have approved Europe's first clinical trial of a monoclonal antibody produced from genetically modified plants. This landmark decision sets the stage for the testing, in humans, of an anti-HIV product made from genetically modified tobacco plants. It will open the door for trials of additional plant-derived medicines treating a range of diseases.

The trial will test the safety of a plant-derived antibody designed to stop the transmission of HIV between sexual partners when applied directly to the vaginal cavity. If proven safe in the 11 participants, the researchers can then go on to test the effectiveness of the product.

The clinical trial marks the culmination of the EU Framework 6 Pharma-Planta project, which was launched by a consortium of 30 academic and industrial partners in 2004 with 12 million in funding from the European Union. The primary goal was to develop an approved manufacturing process for recombinant pharmaceutical proteins made in plants and take one such product through all the development stages including the pivotal clinical trial.

Most biopharmaceuticals are currently made at great expense in fermentation vats containing bacteria or mammalian cells, but the mass production of medicines in genetically modified plants could reduce costs and therefore make an important contribution to global health, by improving access for the poor in developing countries where diseases such as HIV are a huge problem. In addition, the simple manufacturing process could be transferred to developing countries allowing production "in the region for the region".

The approval granted by the UK Medicines and Healthcare products Regulatory Agency (MHRA) is a significant step forwards because it means a plant-based production system can comply with current Good Manufacturing Practice
'/>"/>

Contact: Dr. Rainer Fischer
rainer.fischer@ime.fraunhofer.de
49-241-608-511-021
Fraunhofer-Gesellschaft
Source:Eurekalert

Page: 1 2

Related biology news :

1. Omnicare Clinical Research Re-Brands as Theorem Clinical Research
2. NCI partners with Jackson Laboratory, UC Davis to speed cancer clinical trials
3. TGen Drug Development partners with Imaging Endpoints for comprehensive clinical trial services
4. New clinical trial to test novel approach to treat triple-negative breast cancer
5. The use of placebo in rheumatoid arthritis clinical trials may negatively impact patients
6. Clinical study suggests estrogen levels and breast health can be altered
7. Progress toward the clinical application of autologous induced pluripotent stem cells and gene repair therapy for treatment of familial hypercholesterolemia
8. New cancer drug discovered at U-M heads to clinical trials
9. JAMIA: Evaluating clinical information systems, patients who use PHRs, how clinicians use EHRs
10. Preview of oral presentations at the 1st IOF-ESCEO Pre-Clinical Symposium
11. Press registration open for clinical nutrition conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. ... Online (FIDO ® ) Alliance tm , an ... FIDO members commit to share technology and collaborate ... that are interoperable, more secure and private, and ... biometric identity verification that protects sensitive user information ...
(Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ) has ... - NEC" report to their offering. ... to supply a range of IT security management and ... on the development of a Big Data and cloud ... Asia-Pacific region is a core ...
(Date:4/2/2015)... Germany , April 2, 2015 ... fingerprint tests DERMALOG by far outperforms the strongest ... always maintaining high accuracy, the system is capable ... Hence, the speed proves up to be ten ... faster than its runner-up performance.      ...
Breaking Biology News(10 mins):HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3NEC Security Competitive Profile 2015 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3
... penguins in Antarctica than was previously thought, according to ... of researchers using high-resolution satellite mapping technology. This first-ever ... important benchmark for monitoring the impact of environmental change ... from the University of Minnesota Polar Geospatial Center co-authored ...
... press release is available in German . , ... beings in their own right. This changed about one billion years ... cells. Since then, they have lost much of their autonomy. As ... into the cell nucleus; today, chloroplasts would no longer be able ...
... Calif.All animals seem to have ways of exchanging informationmonkeys ... and fireflies light up their bellies to attract mates. ... among the most abundant animals on the planet, little ... led by California Institute of Technology (Caltech) biologists has ...
Cached Biology News:Scientists complete first-ever emperor penguin count from space 2Direct transfer of plant genes from chloroplasts into the cell nucleus 2Decoding worm lingo 2Decoding worm lingo 3
(Date:5/21/2015)... W. R. Grace & Co. ... Worms, Germany has received good manufacturing practice (GMP) ... International Pharmaceutical Excipient Council (IPEC) Foundation. ... SYLOID® FP brand of pharmaceutical grade excipient silica ... Curtis Bay, Maryland (USA) and Sorocaba, Brazil locations. ...
(Date:5/21/2015)...  CytRx Corporation (NASDAQ: CYTR ), a ... today announced positive updated results from its ongoing ... treatment of unresectable glioblastoma multiforme (GBM), a deadly ... is designed to investigate the preliminary efficacy and ... progressed following prior treatment with surgery, radiation and ...
(Date:5/21/2015)... DUBLIN , May 20, 2015 Research ... announced the addition of the "2015 Global ... to their offering. The primary goal ... of flow cytometry instruments and reagents. Key information ... drive the selection of flow cytometers, predominantly used ...
(Date:5/21/2015)... May 21, 2015 Veolia’s environmental ... exclusive North American distribution agreement with VWR to ... , With more than 160 years of experience, ... services for laboratory and production facilities, has cultivated ... and differentiated services to enable science. Endetec’s ...
Breaking Biology Technology:Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Global Survey on Flow Cytometry Adoption Trends 2015 2Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2
... Tests Improve Cancer Identification, Help Physicians Develop More Specific ... ... March 3 The Center for Molecular,Medicine (CMM) today announced an ... physicians personalize cancer,treatment., The AviaraDx tests can provide physicians greater ...
... - Trent 1000 engines have been selected, - New environmental partnership ... ... burn, SOUTH NORWALK, Conn., March 3 ... has selected,Rolls-Royce Trent 1000 engines to power its Boeing 787-9 fleet of ...
... ROBODOC, a Curexo,Technology Company, and IBM announced ... Cross licensing agreement. The terms of the agreement ... to its current surgical robotics patents, this agreement,gives ... IBM,S Global Portfolio,and particularly, IBM,s surgical robotics patents., ...
Cached Biology Technology:Center for Molecular Medicine Partners with AviaraDx to Offer New Cancer Tests to Aid Physicians in Personalizing Treatment 2Center for Molecular Medicine Partners with AviaraDx to Offer New Cancer Tests to Aid Physicians in Personalizing Treatment 3Virgin Atlantic Selects Rolls-Royce Engines to Power Its 787 Fleet in a Deal Worth $2.6BN 2Virgin Atlantic Selects Rolls-Royce Engines to Power Its 787 Fleet in a Deal Worth $2.6BN 3Virgin Atlantic Selects Rolls-Royce Engines to Power Its 787 Fleet in a Deal Worth $2.6BN 4ROBODOC(R) Announces Patent Cross Licensing Agreement With IBM 2
... pre-validated SNP sequencing services ... within 93 genes including ... more than 80 tyrosine ... were developed and validated ...
... 384-Well Microarray plates are ideal for use as ... liquid handling applications (down to 5µl). These plates ... well design. Features 384 ... available 70µl well volume (cylindrical well), 55µl ...
Anti-Phospho-JKK/SEK1/MKK4 pAb Description: 100 g rabbit polyclonal antibody. Reacts with human/mouse/rat. Tested in WB. Research Focus: signal transduction Storage: -20C Shipping Tem...
...
Biology Products: